Neoss’ objective is to advance the science of dental implant treatment and build a significant and profitable dental implant company recognised for leading innovation, customer focus and ethical principles. Recent product launches include the Neoss Tapered implant launched in 2012; the Neoss Esthetiline Solution, launched in 2011, is the first to provide seamless restorative integration all the way through from implant placement to final crown restoration. The Neoss ProActive®, launched in 2009, features an implant surface that enhances protein aggregation and can accelerate fibrin network formation. Studies show that the, patent pending, etched and blasted ProActive implant surface stimulates bone to form more rapidly and with a greater strength at the implant interface. The Company, founded in 2000 by Doctor Neil Meredith and CTO, Fredrik Engman, is headquartered in Harrogate, UK with operations in USA, Germany, Austria, Italy, Sweden, Australia and New Zealand as well as representation in Switzerland, Ireland, Croatia, Denmark, Republic of Ireland, Czech Republic, Netherlands, Spain, Slovakia, Poland, Turkey, Japan, Thailand and Taiwan by exclusive distributors. For more information, see www.neoss.com.